7281 - 7290 of 9148 Results
Title
Year
-
OPENTitle: Construct optimization for AAV-mediated human α-syn overexpression, and validation across research settings: Development of a shared tool for the research communityJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 5Start Page: 1877718X261447105End Page: 1877718X261447105Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261447105Best OA location URL: https://doi.org/10.1177/1877718x261447105Citation Count: 0
-
OPENTitle: Parkinson's disease drug therapies in the clinical trial pipeline: 2015–2024Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261454154End Page: 1877718X261454154Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261454154Best OA location URL: https://doi.org/10.1177/1877718x261454154Citation Count: 0
-
OPENTitle: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.70672Best OA location URL: https://doi.org/10.1002/mdc3.70672Citation Count: 0
-
OPENTitle: Functional Blood‐Brain Barrier Crossing by Biomimetic M13 Phage Vectors for Targeted Neuronal DeliveryJournal Name: Advanced Healthcare MaterialsPublisher: WileyVol: 15Issue #: 28Start Page: e00029End Page: e00029Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adhm.202600029Best OA location URL: https://doi.org/10.1002/adhm.202600029Citation Count: 0
- Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78248Citation Count: 1
-
OPENTitle: LRRK2 G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environmentJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-026-03967-0Best OA location URL: https://doi.org/10.1186/s12974-026-03967-0Citation Count: 5
- Analysis of EEG for Parkinson’s Disease Detection2022RESTRICTEDTitle: Analysis of EEG for Parkinson’s Disease DetectionJournal Name: 2022 IEEE International Conference on Signal Processing and Communications (SPCOM)Publisher: IEEEVol:Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/spcom55316.2022.9840776Citation Count: 8
- Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease2023RESTRICTEDTitle: Transdermal Nicotine Treatment and Progression of Early Parkinson’s DiseaseJournal Name: NEJM EvidencePublisher: Massachusetts Medical SocietyVol: 2Issue #: 9Start Page: EVIDoa2200311End Page: EVIDoa2200311Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1056/evidoa2200311Citation Count: 26
-
OPENTitle: Money without collaboration won't bring curesJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 19Issue #: 2Start Page: 127End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nm0213-127Best OA location URL: https://www.nature.com/articles/nm0213-127.pdfCitation Count: 4
- New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment2026RESTRICTEDTitle: New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatmentJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 6Start Page: 602End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00090-6Citation Count: 2